Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on TAB. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel alkylation process for (2S)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropionic acid derivatives offers high purity and scalable manufacturing for metabolic syndrome drugs.
Novel six-step route for lenalidomide metabolite ensures high purity and cost efficiency for pharmaceutical research and supply chain stability.
Patent CN101497639B details a scalable Decitabine synthesis using toluoyl protection and fractional crystallization, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN103626822B details a high-yield, mercury-free synthesis of 25-hydroxycholesterol, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113149851A details a high-yield 4-step synthesis for stable isotope labeled chlorpropaline, offering cost-effective solutions for residue detection.
Patent CN119039210A reveals efficient synthesis for light stabilizers ensuring high purity and cost reduction in polymer additive manufacturing supply chains.
Patent CN109553610A details a novel six-step synthesis for emtricitabine isomers offering high purity and scalable manufacturing processes for global supply chains.
Patent CN100569790C reveals a high-yield 3-step route for Capecitabine intermediates using triphosgene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel catalytic route for Capecitabine using 5-deoxy-D-ribofuranose derivatives, offering high yield and mild conditions for API manufacturing.
Patent CN108239128A reveals TMSOTf catalysis for high-purity beta-nucleosides. Enhances supply chain reliability and cost reduction in pharma manufacturing.
Patent CN105111073A details a high-yield synthesis for Higher Alkanol Gallate. Discover cost-effective production and supply chain advantages for food additives.
Novel patent CN116751193B offers high-yield emtricitabine synthesis. Reduces costs and improves supply chain reliability for global pharmaceutical manufacturers.
Patent CN106478747B reveals high-yield sulfonated sugar synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Novel resin-catalyzed synthesis ensures high purity gallic acid esters. Cost-effective manufacturing and reliable supply chain for global food additive procurement.
Discover the novel catalytic route for UV-1600 and UV-479 intermediates. Enhanced purity, reduced waste, and scalable manufacturing for high-performance polymer additives.
Patent CN108440623A reveals a novel silylation-free route for Capecitabine Intermediate. Achieve higher purity and reduced manufacturing costs with scalable supply.
Patent CN1526711A details a scalable Reformatsky process for Gemcitabine intermediates, offering high stereoselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN101391997B details a safer emtricitabine intermediate synthesis using triphosgene. Discover cost reduction in API manufacturing and enhanced supply chain reliability.
Novel patent CN104109182A details high purity gemcitabine hydrochloride synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.